Informatics: Opportunities & Applications. Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit
|
|
|
- Gerald Anthony
- 10 years ago
- Views:
Transcription
1 Informatics: Opportunities & Applications Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit
2 Routine Data "routine data" is data collected as byproducts of clinical care by the clinician and as an integral part of the process of care. Williams JG, BMJ 1995;310; Secondary data : collected by someone else then used by researcher
3 From birth to death
4 Why use routine data? Already collected in many different healthcare and administrative settings Collection process not intrusive to target population Retrospective data available which is regularly updated Studies can be done now Costs of using data lower than for prospective collection Potential for datasets to be linked giving rich source of information about large numbers of patients with different conditions across diverse geographical and healthcare settings Collected in a consistent way Ethical and consent issues can be less problematic
5 Epidemiology Identify patients with specific disease or taking a specific treatment Use hospitalisations and death data to build-up clinical histories and investigate outcomes Support clinical trials Support feasibility studies and patient recruitment Passive follow-up of subjects : cheaper, maximises follow-up Support other research methods Cross-sectoral linkage Act as sampling frame for qualitative studies Research Using Routinely Collected Data
6 Women with breast cancer using endocrine therapy were missing tablets Study: Linking prescribing records to hospital discharge, cancer registry, cancer clinic data and mortality records Results: Low adherence was associated with poorer survival (HR=1.20; 95% CI= , P=0.019) Adherence to medication in women with breast cancer
7 WOSCOPS follow-up % Landmark trial of statin use in patients with no previous CHD Study: Use record linkage of trial data to hospital discharge, cancer registry, and mortality records Results: Placebo Pravastatin Years since randomisation CHD death or CHD event
8 Cancer Screening in Women in Glasgow Lower uptake of bowel screening in women than for breast or cervical screening Study: Link screening records and examine difference in characteristics for uptake. Invite women for interview to explain why they use other cancer screening services but not bowel National Awareness and Early Diagnosis Initiative (NAEDI)
9
10
11 Scottish Health Informatics Programme
12 Creating safe settings and data security SHIP Blueprint highlights: Safe Projects Safe People Safe Data Safe Settings Safe Outputs
13 Safe Settings Thomas and Walport Data Sharing Review (2008): environments for population based research and statistical analysis in which the risk of identifying individuals is minimised
14 Safe Settings
15 Scottish Developments Farr Institute links centres from London, Manchester, Scotland and Swansea Scotland has 6 Universities plus NSS in partnership Core components Physical centres Safe havens e-infrastructure New data access Communication
16 Electronic Data Research and Innovation Service (edris) Glasgow Safe Haven Lothian Safe Haven
17
18 Predicting methotrexate response and toxicity using an integrated polyomic approach (PROMISE-RA) Study: Link clinical data from prescribing records and outpatient visits (SERA) to genetic data from sequenced samples Stratified Medicine Scotland - Innovation Centre
19 NHS Scotland funded programme to harness existing health data to support clinicians in improving patient outcomes and reduce harm from community and healthcare acquired infection Infection Intelligence platform Study: Link national Datasets pertinent to the comprehensive analysis of patterns in infection treatment, prevention, surveillance and clinical outcome
20
Hormone therapy and breast cancer: conflicting evidence. Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group
Hormone therapy and breast cancer: conflicting evidence Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group The world of hormone therapy in the 1990 s Throughout the 1970s, 1980s and 1990s
Big Data for Population Health
Big Data for Population Health Prof Martin Landray Nuffield Department of Population Health Deputy Director, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery University of Oxford
Individual Referencing Systems. Anthea Springbett Programme Principal SHIS-R NHS Information Services Division
Individual Referencing Systems Anthea Springbett Programme Principal SHIS-R NHS Information Services Division Structure of workshop Introduction Referencing and linkage ISD linkage CHI Practical application
Guideline for the Follow Up of Patients Following Treatment for Breast Cancer
Guideline for the Follow Up of Patients Following Treatment for Breast Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Page 1 of 6 1 Scope of the Guideline This guideline
Data platforms to support research, evaluation & practice. David V Ford Professor of Health Informatics School of Medicine, Swansea University
Data platforms to support research, evaluation & practice David V Ford Professor of Health Informatics School of Medicine, Swansea University Outline 1. Swift overview of SAIL Databank as used in Wales
With Big Data Comes Big Responsibility
With Big Data Comes Big Responsibility Using health care data to emulate randomized trials when randomized trials are not available Miguel A. Hernán Departments of Epidemiology and Biostatistics Harvard
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE CRUK Stratified Medicine Initiative Somatic mutation testing for prediction of treatment response in patients with solid tumours:
This vision does not represent government policy but provides useful insight into how breast cancer services might develop over the next 5 years
Breast Cancer 2015 Annex C Background 1. Breast cancer is the most common cancer in women in England with (not including cases of ductal carcinoma in situ (DCIS) 1 ) 39,681 new cases diagnosed in 2008
Big Data for health. Farr Institute, Administrative Data Research Centres, Medical Bioinformatics. 9 July 2015. Jacky Pallas, UCL
Big Data for health Farr Institute, Administrative Data Research Centres, Medical Bioinformatics 9 July 2015 Jacky Pallas, UCL Overview UK Research Council funding for big data in health, medical and administrative
Key Health Areas Mapped to Out of Hospital Programme Areas
1 Key Area (according to letter from David Nicholson) Reducing the number of years of life lost by the people of England from treatable conditions (e.g. including cancer, stroke, heart disease, respiratory
NHS outcomes framework and CCG outcomes indicators: Data availability table
NHS outcomes framework and CCG outcomes indicators: Data availability table December 2012 NHS OF objectives Preventing people from dying prematurely DOMAIN 1: preventing people from dying prematurely Potential
THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR)
THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR) Professor Nico van Zandwijk Director Asbestos Diseases Research Institute US US UK UK COUNTRY NZ CAN COUNTRY NZ CAN AUS AUS Mesothelioma International context
Analysis of Population Cancer Risk Factors in National Information System SVOD
Analysis of Population Cancer Risk Factors in National Information System SVOD Mužík J. 1, Dušek L. 1,2, Pavliš P. 1, Koptíková J. 1, Žaloudík J. 3, Vyzula R. 3 Abstract Human risk assessment requires
Information Governance. A Clinician s Guide to Record Standards Part 1: Why standardise the structure and content of medical records?
Information Governance A Clinician s Guide to Record Standards Part 1: Why standardise the structure and content of medical records? Contents Page 3 A guide for clinicians Pages 4 and 5 Why have standards
Big Data for Population Health and Personalised Medicine through EMR Linkages
Big Data for Population Health and Personalised Medicine through EMR Linkages Zheng-Ming CHEN Professor of Epidemiology Nuffield Dept. of Population Health, University of Oxford Big Data for Health Policy
Randomized trials versus observational studies
Randomized trials versus observational studies The case of postmenopausal hormone therapy and heart disease Miguel Hernán Harvard School of Public Health www.hsph.harvard.edu/causal Joint work with James
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics Response by the Genetic Interest Group Question 1: Health
Swedish RWE a goldmine?
Swedish RWE a goldmine? How is Novartis using Swedish RWE to improve decision making? Madlaina Costa, Head Health Economics and Pricing, Novartis Sweden RWE in Europe, Amsterdam 3 rd June 2015 Swedish
Likelihood of Cancer
Suggested Grade Levels: 9 and up Likelihood of Cancer Possible Subject Area(s): Social Studies, Health, and Science Math Skills: reading and interpreting pie charts; calculating and understanding percentages
The 100,000 genomes project
The 100,000 genomes project Tim Hubbard @timjph Genomics England King s College London, King s Health Partners Wellcome Trust Sanger Institute ClinGen / Decipher Washington DC, 26 th May 2015 The 100,000
Improving survival and Clinical Trials Janyne Afseth Lecturer Edinburgh Napier University
Improving survival and Clinical Trials Janyne Afseth Lecturer Edinburgh Napier University Aims Identify the factors which may link to improved survival to clinical trials in cancer Describe some of impact
Cancer research in the Midland Region the prostate and bowel cancer projects
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
Everolimus plus exemestane for second-line endocrine treatment of oestrogen receptor positive metastatic breast cancer
LONDON CANCER NEWS DRUGS GROUP RAPID REVIEW Everolimus plus exemestane for second-line endocrine treatment of oestrogen receptor positive metastatic breast cancer Everolimus plus exemestane for second-line
Measuring quality along care pathways
Measuring quality along care pathways Sarah Jonas, Clinical Fellow, The King s Fund Veena Raleigh, Senior Fellow, The King s Fund Catherine Foot, Senior Fellow, The King s Fund James Mountford, Director
Executive Summary and Recommendations: National Audit of Learning Disabilities Feasibility Study
Executive Summary and Recommendations: National Audit of Learning Disabilities Feasibility Study Contents page Executive Summary 1 Rationale and potential impact of a future audit 2 Recommendations Standards
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal
Transforming Care After Treatment and the Ayrshire Experience
Transforming Care After Treatment and the Ayrshire Experience The overall aim of the programme is to ensure that people affected by cancer in Scotland, are prepared and supported to live with the consequences
PATIENT INFORMATION SHEET
PATIENT INFORMATION SHEET Surgical and large bore pleural procedures in Malignant pleural Mesothelioma And Radiotherapy Trial (SMART trial) Stoke Mandeville Hospital Mandeville Road Aylesbury Buckinghamshire
No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008
COUNCIL OF THE EUROPEAN UNION Brussels, 22 May 2008 9636/08 SAN 87 NOTE from: Committee of Permanent Representatives (Part 1) to: Council No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY,
Patient Information Leaflet: Part 1 select-d
Patient Information Leaflet: Part 1 select-d Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism Introduction This
National Horizon Scanning Centre. Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer. December 2007
Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer December 2007 This technology summary is based on information available at the time of research and a limited literature search.
CPRD Clinical Practice Research Datalink [email protected] Scotland Meeting May 2012
CPRD Clinical Practice Research Datalink [email protected] Scotland Meeting May 2012 Computational Biochemist PhD Liverpool Pharma Healthcare Food Advertising JWT Healthcare Medical Education UoD
Breast Cancer Care & Research
Breast Cancer Care & Research Professor John FR Robertson University of Nottingham Nottingham City Hospital Breast Cancer (BC) 15,000 BC deaths in the UK each year 20% female cancer deaths 5% all female
School of Public Health and Health Services Department of Prevention and Community Health
School of Public Health and Health Services Department of Prevention and Community Health Master of Public Health and Graduate Certificate Health Promotion 2013 2014 Note: All curriculum revisions will
Secondary Uses of Data for Comparative Effectiveness Research
Secondary Uses of Data for Comparative Effectiveness Research Paul Wallace MD Director, Center for Comparative Effectiveness Research The Lewin Group [email protected] Disclosure/Perspectives Training:
ECONOMIC COSTS OF PHYSICAL INACTIVITY
ECONOMIC COSTS OF PHYSICAL INACTIVITY This fact sheet highlights the prevalence and health-consequences of physical inactivity and summarises some of the key facts and figures on the economic costs of
Arthritis Research UK Epidemiology Unit
Arthritis Research UK Epidemiology Unit Qualitative research proposal to explore factors influencing acceptable risk thresholds used to recommend particular treatment options for rheumatoid arthritis.
Health Data Governance: Privacy, Monitoring and Research - Policy Brief
Health Data Governance: Privacy, Monitoring and Research - Policy Brief October 2015 www.oecd.org/health Highlights All countries can improve their health information systems and make better use of data
Cancer Treatment Planning: A Means to Deliver Quality, Patient-Centered Care
Cancer Treatment Planning: A Means to Deliver Quality, Patient-Centered Care Patricia A. Ganz, M.D. Jonsson Comprehensive Cancer Center UCLA Schools of Medicine & Public Health Overview of Presentation
Does my project require review by a Research Ethics Committee?
National Research Ethics Service Does my project require review by a Research Ethics Committee? This algorithm is designed to assist researchers, sponsors and R&D offices in determining whether a project
CLINICAL RESEARCH NETWORK
CLINICAL RESEARCH NETWORK Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the
Tjeerd van Staa Professor of Health eresearch Centre for Health Informatics, University of Manchester
Tjeerd van Staa Professor of Health eresearch Centre for Health Informatics, University of Manchester Disclosure statement I have participated in expert meetings with GSK and Boehringer and provided methodological
HSCIC Statistical Publications
Author Julie Stroud Date 31 March 2015 1 Copyright 2015, Health and Social Care Information Centre. Contents Contents 2 Purpose 3 Background to HSCIC Official Statistics 3 Forthcoming Publications 3 Official
Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners
Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners Questions and Answers May 2014 Health Protection Scotland
BIG DATA SCIENTIFIC AND COMMERCIAL APPLICATIONS (ITNPD4) LECTURE: DATA SCIENCE IN MEDICINE
BIG DATA SCIENTIFIC AND COMMERCIAL APPLICATIONS (ITNPD4) LECTURE: DATA SCIENCE IN MEDICINE Gabriela Ochoa http://www.cs.stir.ac.uk/~goc/ OVERVIEW Module My Contributions Description: with guest lectures
Service Specification Template Department of Health, updated June 2015
Service Specification Template Department of Health, updated June 2015 Service Specification No. : 2 Service: Commissioner Lead: Provider Lead: Period: Anti-coagulation monitoring Date of Review: 31 st
Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health
Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health Introduction Reader (Statistics and Epidemiology) Research team epidemiologists/statisticians/phd students Primary care
Health Information. Technology and Cancer Information Management. Health Information Technology & Cancer Information Management 363
Health Information Technology & 363 Health Information Technology and Cancer Information Management Opportunities in the health information field have expanded with changes in health care delivery, utilization
Whitehall II Data Collection Procedure Phases 11 and 12
Whitehall II Data Collection Procedure Phases 11 and 12 Version 2 March 2015 Dr Aida Sanchez With the collaboration of Therese Butler, Beverly Milne, Stephanie Smith Whitehall II Department of Epidemiology
Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)
Early mortality rate (EMR) in Acute Myeloid Leukemia (AML) George Yaghmour, MD Hematology Oncology Fellow PGY5 UTHSC/West cancer Center, Memphis, TN May,1st,2015 Off-Label Use Disclosure(s) I do not intend
Taking Part in Research at University Hospitals Birmingham
University Hospitals Birmingham NHS Foundation Trust The Trust provides free monthly health talks on a variety of medical conditions and treatments. For more information visit www.uhb.nhs.uk or call 0121
Using 'Big Data' to Estimate Benefits and Harms of Healthcare Interventions
Using 'Big Data' to Estimate Benefits and Harms of Healthcare Interventions Experience with ICES and CNODES DAVID HENRY, PROFESSOR OF HEALTH SYSTEMS DATA, UNIVERSITY OF TORONTO, SENIOR SCIENTIST, INSTITUTE
Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data
Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data Prepared for the 138th Annual Meeting of the American Public Health Association Denver, CO
Public Health Training Prospectus
Greater Manchester Public Health England Centre Public Health Training Prospectus Issue Date: February 2015 Review Date: July 2015 About Public Health England PHE exists to protect and improve the nation's
Clinical Practice Guidance for the Assessment of Young Women aged 20-24 with Abnormal Vaginal Bleeding
Clinical Practice Guidance for the Assessment of Young Women aged 20-24 with Abnormal Vaginal Bleeding Clinical Practice Guidance for the Assessment of Young Women aged 20-24 with Abnormal Vaginal Bleeding
Big data and connected challenges in cardiovascular health
Big data and connected challenges in cardiovascular health Harry Hemingway FFPH, FRCP Professor of Clinical Epidemiology Director Institute of Health Informatics, UCL Director Farr Institute, London IUCL
References. Tobacco-Free Schools
References 73 1 Taulbut M, Gordon D, McKenzie K. 2008. Tobacco smoking in Scotland: an epidemiology briefing. Edinburgh: NHS Health Scotland and Scottish Public Health Observatory. Available from: www.scotpho.org.uk/publications/reports-and-papers/493-tobacco-smoking-inscotland-an-epidemiology-briefing
Recruiting now. Could you help by joining this study?
Non-Small Cell Lung Cancer Recruiting now AstraZeneca is looking for men and women with locally advanced or metastatic non-small cell lung cancer (NSCLC) to join ATLANTIC, a clinical study to help investigate
Evaluation of a Primary Care Dermatology Service: final report
Evaluation of a Primary Care Dermatology Service: final report Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO) December 2005 prepared by Chris Salisbury*
Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.
Proposed PAHO Plan of Action for Cancer Prevention and Control 2008 2015 Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.
What you should know about Data Quality. A guide for health and social care staff
What you should know about Data Quality A guide for health and social care staff Please note the scope of this document is to provide a broad overview of data quality issues around personal health information
How To Prepare A Meeting For A Health Care Conference
THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App
Jill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
Big Data and Oncology Care Quality Improvement in the United States
Big Data and Oncology Care Quality Improvement in the United States Peter P. Yu, MD, FACP, FASCO President, American Society of Clinical Oncology Director of Cancer Research, Palo Alto Medical Foundation
Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care
Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
